Today: 29 April 2026
Lloyds share price edges lower as buyback rolls on and UK rates loom
27 February 2026
1 min read

Lloyds share price edges lower as buyback rolls on and UK rates loom

London, Feb 27, 2026, 09:07 GMT — Regular session

  • Lloyds edged 0.1% lower shortly after the London open.
  • Bank reported buying back 8 million shares on Feb 26
  • UK rates and policy cues for March are under traders’ scrutiny.

Lloyds Banking Group plc (LLOY.L) edged down 0.1% to 104.8 pence in early London trading on Friday. The move, though slight, follows the latest buyback update and keeps the spotlight on the lender’s shares. The stock started at 104.2 pence, with trades so far ranging from 103.65 up to 104.9 pence.

Why it’s in focus: Lloyds leans hard on the UK market, so its profits often rise or fall with local interest rates and how busy the mortgage business gets. Capital returns are a big piece here as well; buybacks boost EPS by cutting the number of shares out there, even in stretches when top-line growth is spotty.

Lloyds picked up 8 million ordinary shares on Thursday, according to a regulatory filing, paying a volume-weighted average of 104.4873 pence apiece. Prices spanned from 104.05 to 104.95 pence. Goldman Sachs International was the seller. The group plans to cancel the shares.

The buyback comes as part of a broader capital-return package detailed with full-year numbers at the end of last month. Lloyds showed a 12% increase in 2025 pretax profit, hitting 6.7 billion pounds, and rolled out a 1.75 billion-pound buyback. The bank also upped its profitability target, now aiming for return on tangible equity north of 16% by 2026. “Ongoing strategic execution and momentum,” is how CEO Charlie Nunn summed up the results. Reuters

UK stocks pushed to fresh highs on Thursday, lifted by strong performances from major names and ongoing hopes for stable rate cuts. “It is likely that the UK index’s outperformance is here to stay,” said Axel Rudolph, senior financial analyst at IG, highlighting the market’s lower valuations relative to tech-heavy U.S. counterparts. Reuters

UK bank stocks edged lower, with Barclays sliding at the open after The Times flagged possible losses tied to the collapse of mortgage provider Market Financial Solutions. Citi analysts said the headline exposure “may warrant some caution,” but stressed that arranging a loan isn’t the same as carrying the risk on Barclays’ own books. Reuters

Lloyds notified investors that its UK shares go ex-dividend on April 9, so anyone picking them up after that date won’t receive the next payout. The final 2025 dividend lands on May 19.

Still, buybacks don’t always provide steady support—if rates move unexpectedly, that cushion can disappear in a hurry. Quick rate cuts tend to pinch net interest margin, the difference between what banks take in from loans and what they shell out for deposits. And if the housing market softens, lending growth and credit quality can take a hit, too.

Coming Tuesday, March 3, Chancellor Rachel Reeves will unveil revised economic forecasts. The UK Debt Management Office also updates its debt issuance plans that day—both of which can shift gilt yields and, with them, UK bank valuations.

Stock Market Today

  • Top TSX Stocks to Watch Before Market Shifts: Dye & Durham, Tecsys, Kinaxis
    April 29, 2026, 5:40 PM EDT. Investors eyeing the Toronto Stock Exchange should consider Dye & Durham (TSX:DND), Tecsys (TSX:TCS), and Kinaxis (TSX:KXS) ahead of potential market moves. Dye & Durham faces challenges with declining revenue and net losses but trades at a low price-to-sales ratio, reflecting value amid activist and takeover pressures. Tecsys's focus on healthcare supply chain software fuels revenue and Software-as-a-Service (SaaS) growth, with cost-cutting measures boosting profitability despite a high valuation. Kinaxis offers supply chain orchestration software, positioned well for recurring revenue growth. These companies feature sticky customers, improving earnings, and business models potentially resilient to volatility, making them smart considerations for investors seeking TSX growth stocks.

Latest article

Chipotle Stock Jumps After Chicken Bet Breaks Its Sales Slump

Chipotle Stock Jumps After Chicken Bet Breaks Its Sales Slump

29 April 2026
Chipotle Mexican Grill reported a 0.5% rise in first-quarter comparable sales, reversing recent declines and beating analyst expectations. Total revenue rose 7.4% to $3.09 billion, while shares jumped 7% in after-hours trading. Operating margin narrowed to 12.9% from 16.7% a year earlier. Menu items like Chicken al Pastor and Honey Chicken drove increased restaurant visits.
AI Stocks Today: Big Tech Earnings Just Put the Market’s Hottest Trade on Notice

AI Stocks Today: Big Tech Earnings Just Put the Market’s Hottest Trade on Notice

29 April 2026
Alphabet shares jumped over 3% in after-hours trading Wednesday as Google Cloud revenue surged 63% to $20 billion. Meta, Amazon, and Microsoft fell, with Meta dropping more than 6% after raising its 2026 capital spending forecast for AI infrastructure. Amazon’s AWS revenue beat estimates but shares slipped. The four companies are expected to spend over $600 billion on AI infrastructure this year.
Ford’s $1.3 Billion Tariff Refund Lifted Its 2026 Outlook. Aluminum Is The Catch

Ford’s $1.3 Billion Tariff Refund Lifted Its 2026 Outlook. Aluminum Is The Catch

29 April 2026
Ford raised its 2026 profit outlook after a $1.3 billion tariff refund lifted Q1 net income to $2.5 billion and revenue to $43.3 billion. Adjusted EBIT jumped to $3.5 billion from $1 billion a year earlier. The company flagged $2 billion in 2026 commodity headwinds, mainly from aluminum. Ford Model e lost $777 million in Q1, while F-150 inventory dropped 38% in April after Novelis plant fires.
RELX share price today: stock edges up as buybacks keep traders watching
Previous Story

RELX share price today: stock edges up as buybacks keep traders watching

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Next Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

Go toTop